Price Alert

Autolus Therapeutics (AUTL)

NASDAQ: AUTL · Real-Time Price · USD

1.73

-0.12 (-6.49%)

At close: Aug 15, 2025, 3:59 PM

1.76

1.73%

After-hours: Aug 15, 2025, 07:55 PM EDT

Autolus Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	95.8M	227.38M	657.07M	705.94M	759.54M	239.57M	256.42M	307.5M	343.03M	382.44M	163.05M	216.44M	268.56M	310.34M	173.06M	216.35M	239.01M
Short-Term Investments	420.78M	360.64M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.11M	1.13M	1.23M	1.26M	2.96M	1.36M	1.08M	2.16M	2.29M	4.01M	3.41M	3.72M	4.1M	4.4M	4.31M	4.61M	4.78M
Receivables	65.34M	47.31M	993K	938K	948K	1.05M	41.96M	38.22M	34.84M	153K	2.12M	36.67M	54K	68K	n/a	n/a	39.23M
Inventory	14.65M	4.14M	n/a	-37.06M	n/a	-24.54M	9.88M	9.61M	2.33M	14.16M	7.84M	5.64M	8.97M	10.12M	9.76M	8.69M	n/a
Other Current Assets	5.49M	5.32M	46M	39.86M	948K	26.05M	2.47M	2.46M	n/a	30.84M	39.97M	1.08M	33.08M	27.83M	56.37M	46.66M	2.34M
Total Current Assets	615.77M	660.93M	718.11M	758.6M	802.64M	275.3M	308.38M	355.37M	393.88M	425.77M	212.31M	258.96M	309.46M	346.95M	237.68M	269.51M	288.06M
Property-Plant & Equipment	114.22M	105.05M	104.76M	90.54M	92.54M	95.65M	94.04M	91.11M	61.53M	58.42M	45.71M	49.02M	48.38M	52.32M	53.16M	54.79M	54.74M
Goodwill & Intangibles	12.47M	12.37M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	8K	25K	46K	65K	87K	112K	135K
Total Long-Term Assets	130.56M	121.8M	109.38M	95.02M	98.8M	100.08M	97.72M	95.63M	66.09M	64.5M	51.52M	55.02M	54.53M	58.61M	58.96M	61.15M	61.69M
Total Assets	746.34M	782.73M	827.49M	853.62M	901.44M	375.38M	406.1M	450.99M	459.97M	490.27M	263.83M	313.98M	363.99M	405.56M	296.64M	330.65M	349.75M
Account Payables	4.46M	1.97M	1.42M	1.1M	1.4M	103K	661K	3.88M	353K	531K	334K	162K	153K	431K	7K	1.12M	429K
Deferred Revenue	4.72M	n/a	n/a	10.43M	n/a	-5.16M	30.91M	30.7M	n/a	n/a	n/a	n/a	n/a	23.52M	28.32M	22.5M	24.11M
Short-Term Debt	n/a	3M	3.57M	4.23M	n/a	5.05M	5.49M	n/a	n/a	5.04M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	23.37M	23.66M	19.41M	20.89M	26.51M	19.77M	5.16M	259K	26.65M	25.58M	881K	24.47M	17M	14.92M	1.77M	678K	17.82M
Total Current Liabilities	66.61M	60.74M	52.47M	40.9M	43.98M	44.74M	37.54M	41.06M	39.64M	46.37M	38.82M	35.52M	28.84M	28.55M	34.56M	28.19M	30.6M
Long-Term Debt	n/a	n/a	n/a	238.66M	228.49M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	253.88M	245.03M	249.39M	415K	409K	171.26M	141.07M	135.89M	130.92M	126.02M	52.55M	50.73M	48.93M	47.14M	n/a	n/a	n/a
Total Long-Term Liabilities	308.62M	294.66M	298.05M	284.87M	275.42M	219.17M	188.04M	180.59M	153.41M	145.23M	63.86M	63.94M	64.01M	63.69M	17.34M	18.79M	19.58M
Total Liabilities	375.23M	355.4M	350.52M	325.78M	319.41M	263.91M	225.58M	221.66M	193.05M	191.6M	102.68M	99.45M	92.85M	92.24M	51.91M	46.97M	50.18M
Total Debt	57.71M	52.63M	52.23M	288.68M	279.83M	52.97M	52.46M	50.94M	27.32M	24.26M	15.13M	17.2M	19.25M	21M	21.81M	22.68M	23.24M
Common Stock	12K	12K	12K	12K	130K	8K	8K	8K	8K	8K	4K	4K	4K	4K	3K	3K	3K
Retained Earnings	-1.17B	-1.1B	-1.07B	-989.52M	-931.25M	-878.56M	-801.39M	-755.54M	-709.99M	-670.18M	-643.23M	-600.46M	-558.4M	-521.34M	-479.67M	-445.68M	-412.51M
Comprehensive Income	-18.11M	-29.17M	-898K	-27.91M	-28.93M	-28.99M	-33.79M	-27.96M	-33.26M	-38.9M	-47.56M	-33.51M	-16.02M	-8.57M	-9.51M	-3.05M	-4.59M
Shareholders Equity	371.11M	427.32M	476.96M	527.84M	582.03M	111.47M	180.52M	229.34M	266.92M	298.67M	161.15M	214.52M	271.14M	313.32M	244.73M	283.68M	299.57M
Total Investments	420.78M	360.64M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a